Issue 4/2008
Content (24 Articles)
Risk prediction models with incomplete data with application to prediction of estrogen receptor-positive breast cancer: prospective data from the Nurses' Health Study
Bernard Rosner, Graham A Colditz, J Dirk Iglehart, Susan E Hankinson
Breast cancer stem cells: implications for therapy of breast cancer
Brian J Morrison, Chris W Schmidt, Sunil R Lakhani, Brent A Reynolds, J Alejandro Lopez
Molecular targeted therapies for breast cancer treatment
Claus M Schlotter, Ulf Vogt, Heike Allgayer, Burkhard Brandt
The aromatase inhibitor letrozole and inhibitors of insulin-like growth factor I receptor synergistically induce apoptosis in in vitro models of estrogen-dependent breast cancer
Joanna Lisztwan, Astrid Pornon, Bin Chen, Shiuan Chen, Dean B Evans
Genetic variation in candidate obesity genes ADRB2, ADRB3, GHRL, HSD11B1, IRS1, IRS2, and SHC1 and risk for breast cancer in the Cancer Prevention Study II
Heather Spencer Feigelson, Lauren R Teras, W Ryan Diver, Weining Tang, Alpa V Patel, Victoria L Stevens, Eugenia E Calle, Michael J Thun, Mark Bouzyk
Variation in breast cancer risk in BRCA1 and BRCA2 mutation carriers
Timothy R Rebbeck, Susan M Domchek
Multifunctional roles of insulin-like growth factor binding protein 5 in breast cancer
Mustafa Akkiprik, Yumei Feng, Huamin Wang, Kexin Chen, Limei Hu, Aysegul Sahin, Savitri Krishnamurthy, Ayse Ozer, Xishan Hao, Wei Zhang
The ubiquitin-like molecule interferon-stimulated gene 15 (ISG15) is a potential prognostic marker in human breast cancer
Nuran Bektas, Erik Noetzel, Jürgen Veeck, Michael F Press, Glen Kristiansen, Amjad Naami, Arndt Hartmann, Arno Dimmler, Matthias W Beckmann, Ruth Knüchel, Peter A Fasching, Edgar Dahl
Evaluation of BRCA1 and BRCA2 mutations and risk-prediction models in a typical Asian country (Malaysia) with a relatively low incidence of breast cancer
E Thirthagiri, SY Lee, P Kang, DS Lee, GT Toh, S Selamat, S-Y Yoon, NA Mohd Taib, MK Thong, CH Yip, SH Teo
Continuing trastuzumab beyond disease progression: outcomes analysis in patients with metastatic breast cancer
Giuseppe Cancello, Emilia Montagna, Diego D'Agostino, Mario Giuliano, Antonio Giordano, Giuseppe Di Lorenzo, Monica Plaitano, Sabino De Placido, Michele De Laurentiis
Genes responsive to both oxidant stress and loss of estrogen receptor function identify a poor prognosis group of estrogen receptor positive primary breast cancers
Christina Yau, Christopher C Benz
Epigenetic mapping and functional analysis in a breast cancer metastasis model using whole-genome promoter tiling microarrays
David I Rodenhiser, Joseph Andrews, Wendy Kennette, Bekim Sadikovic, Ariel Mendlowitz, Alan B Tuck, Ann F Chambers
Over-expression of Skp2 is associated with resistance to preoperative doxorubicin-based chemotherapy in primary breast cancer
Shirly Davidovich, Ofer Ben-Izhak, Ma'anit Shapira, Boris Futerman, Dan D Hershko
Visually assessed breast density, breast cancer risk and the importance of the craniocaudal view
Stephen W Duffy, Iris D Nagtegaal, Susan M Astley, Maureen GC Gillan, Magnus A McGee, Caroline RM Boggis, Mary Wilson, Ursula M Beetles, Miriam A Griffiths, Anil K Jain, Jill Johnson, Rita Roberts, Heather Deans, Karen A Duncan, Geeta Iyengar, Pam M Griffiths, Jane Warwick, Jack Cuzick, Fiona J Gilbert
Meta-analysis of gene expression profiles in breast cancer: toward a unified understanding of breast cancer subtyping and prognosis signatures
Pratyaksha Wirapati, Christos Sotiriou, Susanne Kunkel, Pierre Farmer, Sylvain Pradervand, Benjamin Haibe-Kains, Christine Desmedt, Michail Ignatiadis, Thierry Sengstag, Frédéric Schütz, Darlene R Goldstein, Martine Piccart, Mauro Delorenzi
Breast cancer susceptibility loci and mammographic density
Rulla M Tamimi, David Cox, Peter Kraft, Graham A Colditz, Susan E Hankinson, David J Hunter
Comparison of molecular phenotypes of ductal carcinoma in situand invasive breast cancer
Rulla M Tamimi, Heather J Baer, Jonathan Marotti, Mark Galan, Laurie Galaburda, Yineng Fu, Anne C Deitz, James L Connolly, Stuart J Schnitt, Graham A Colditz, Laura C Collins
Prolactin receptor antagonism reduces the clonogenic capacity of breast cancer cells and potentiates doxorubicin and paclitaxel cytotoxicity
Sacha J Howell, Elizabeth Anderson, Tom Hunter, Gillian Farnie, Robert B Clarke
Enrichment with anti-cytokeratin alone or combined with anti-EpCAM antibodies significantly increases the sensitivity for circulating tumor cell detection in metastatic breast cancer patients
Glenn Deng, Michael Herrler, David Burgess, Edward Manna, David Krag, Julian F Burke
Activated Akt1 accelerates MMTV-c-ErbB2 mammary tumourigenesis in mice without activation of ErbB3
Christian D Young, Erica C Nolte, Andrew Lewis, Natalie J Serkova, Steven M Anderson
Relaxin reduces xenograft tumour growth of human MDA-MB-231 breast cancer cells
Yvonne Radestock, Cuong Hoang-Vu, Sabine Hombach-Klonisch
Variable size computer-aided detection prompts and mammography film reader decisions
Fiona J Gilbert, Susan M Astley, Caroline RM Boggis, Magnus A McGee, Pamela M Griffiths, Stephen W Duffy, Olorunsola F Agbaje, Maureen GC Gillan, Mary Wilson, Anil K Jain, Nicola Barr, Ursula M Beetles, Miriam A Griffiths, Jill Johnson, Rita M Roberts, Heather E Deans, Karen A Duncan, Geeta Iyengar
A robust classifier of high predictive value to identify good prognosis patients in ER-negative breast cancer
Andrew E Teschendorff, Carlos Caldas